Global Clinical Trial Landscape of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Where Are We Headed?

K Luo1, S Liu2, Y Liu3

  • 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, China.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|April 19, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos